Chart Glance- TRGT is a Bio-Tech, High Speculation stock. Not alot can be said regarding TRGTs chart. NO DEMAND at this time and TRGT is currently, Tom Petty, “Free Falling.”
50 DMA ($6.52), 100 DMA ($7.76), 200 DMA ($12.94).
Support 1: NA Support 2: NA
Astrazeneca and Targacepts depression drug, “TC-5214,” DID NOT PASS PHASE III. Astrazeneca invested over $1.25 Billion dollars in the depression drug “TC-5214.” Targacepts CEO, DeBethizy states, “we will announce our plans regarding the Renaissance Program at the end of May of 2012.”
TRGT has a strong balance sheet, with positive cash-flow. If TRGT trades down in the low 5’s I might look to take a stab at it and buy some OTM Calls.
By Greg Zimny